Warfarin-induced leukocytoclastic vasculitis: A case report and review of literature

Internal Medicine

Volumn 51, Issue 6, 2012, Pages 601-606

  Hsu, Chien Yi ^a,b   Chen, Wei Sheng ^a,b   Sung, Shih Hsien ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Leukocytoclastic vasculitis; Warfarin

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; AMIODARONE; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; CAPTOPRIL; CARVEDILOL; COLCHICINE; DIGOXIN; DILTIAZEM; FERROUS SULFATE; FUROSEMIDE; INSULIN; ISOSORBIDE DINITRATE; LEVOTHYROXINE; LOSARTAN; PARACETAMOL; PREDNISONE; RANITIDINE; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECCHYMOSIS; ERYTHEMA; FEVER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMATURIA; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LEG EDEMA; LEUKOCYTOCLASTIC VASCULITIS; LUNG EMBOLISM; MACULOPAPULAR RASH; MALE; PETECHIA; PNEUMONIA; PROTEINURIA; PURPURA; PURPURIC RASH; RASH; REVIEW; SKIN BIOPSY; SKIN DEFECT; VASCULITIS;

ACUTE KIDNEY INJURY; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CORONARY DISEASE; DRUG ERUPTIONS; HEART FAILURE; HUMANS; HYPERTENSION; MALE; PROTEINURIA; TAIWAN; THROMBOPHILIA; VASCULITIS, LEUKOCYTOCLASTIC, CUTANEOUS; WARFARIN;

EID: 84863268863     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6240     Document Type: Review

References (21)

1. Gallerani M, Manfredini R, Moratelli S. Non-haemorrhagic adverse reactions of oral anticoagulant therapy. Int J Cardiol 49: 1-7, 1995.
2. Sallah S, Thomas DP, Roberts HR. Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment. Thromb Haemost 78: 785-790, 1997.
3. Tanay A, Yust I, Brenner S, Koffler M, Abramov AL. Dermal vasculitis due to coumadin hypersensitivity. Dermatologica 165: 178- 185, 1982.
4. Howitt AJ, Willians AJ, Skinner C. Warfarin-induced vasculitis: a dose related phenomenon in susceptible individuals? Postgrad Med J 58: 233-234, 1982.
5. Susano R, Garcia A, Altadill A, Ferro J. Hypersensitivity vasculitis related to nicoumalone. BMJ 10: 306 (6883): 973, 1993.
6. Tamir A, Wolf R, Brenner S. Leukocytoclastic vasculitis: another coumarin-induced hemorrhagic reaction. Acta Derm Venereol 74: 138-139, 1994.
7. Jimenez-Gonzalo FJ, Medina-Perez M, Marin-Martin J. Acenocoumarol-induced leukocytoclastic vasculitis. Haematologica 84: 462-463, 1999.
8. Borras-Blasco J, Girona E, Navarro-Ruiz A, et al. Acenocoumarolinduced Henoch-Schönlein purpura. Ann Pharmacother 38: 261-264, 2004.
9. Yaghoubian B, Ngo B, Mak M, Ostrzega E, Tesoro J, Mitani GH. Warfarin-induced leukocytoclastic vasculitis. Cutis 75: 329-338, 2005.
10. Kurt M, Shorbagi A, Aksu S, Haznedaroglu I, Altundag K, Erkin G. Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency. Blood Coagul Fibrinolysis 18: 805-856, 2007.
11. Aouam K, Gassab A, Khorchani H, et al. Acenocoumarol and vasculitis: a case report. Pharmacoepidemiol Drug Saf 16: 113-114, 2007.
12. Kapoor KG, Bekaii-Saab T. Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis. Intern Med J 38: 281-283, 2008.
13. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245, 1981.
14. Fiorentino DF. Cutaneous vasculitis. J Am Acad Dermatol 48: 311-340, 2003.
15. Bircher AJ, Scherer K. Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am 94: 711-725, 2010.
16. Crowson AN, Mihm MC, Magro CM. Cutaneous vasculitis: a review. J Cutan Pathol 30: 161-173, 2003.
17. ten Holder SM, Joy MS, Falk RJ. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 36: 130-147, 2002.
18. Essex DW, Wynn SS, Jin DK. Late-onset warfarin-induced skin necrosis: case report and review of the literature. Am J Hematol 57: 233-237, 1998.
19. Hirsh J, Dalen JE, Deykin D, Poller L, Bussey H. Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 108 (4 suppl): 231S-246S, 1995.
20. Volpi A, Ferrario GM, Giordano F, et al. Acute renal failure due to hypersensitivity nephritis induced by warfarin sodium. Nephron 52: 196, 1989.
21. Calabrese LH, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. Arthritis Rheum 33: 1108-1113, 1990.